Prognosis
Most neonates with neonatal unconjugated hyperbilirubinaemia do well after phototherapy and/or exchange transfusion. Kernicterus should be preventable if recommendations for hyperbilirubinaemia management are carried out in a timely manner.[9]
For neonates with haemolytic anaemia secondary to blood group incompatibility, haemolysis should not present as a problem once the maternal antibodies are gone.
Babies with polycythaemia and extravasation of blood should not have any problem once the extra haemoglobin breakdown is taken care of.
Surgical causes of increased enterohepatic circulation should resolve once the specific condition is treated. Bilirubin levels of babies with partial specific enzymatic conjugation defects can usually be kept under control with night-time phototherapy.
For babies with conjugated hyperbilirubinaemia, the outlook depends on the aetiology of the condition. The clinical course is variable in babies with alpha 1-antitrypsin deficiency and cystic fibrosis. In babies with Zellweger's syndrome, the prognosis is poor, with most neonates dying during the first year or surviving with profound developmental delay and seizures. Patients with Dubin-Johnson and Rotor's syndromes (inherited as autosomal recessive) have an excellent prognosis. The prognosis of babies with other metabolic/genetic defects depends on early recognition and management of the specific enzyme deficiencies and accumulation of metabolites. Parenteral-induced cholestasis should improve if enteral feeding can be established. Some of the infectious aetiologies (such as congenital syphilis, bacterial) of hepatitis improve with specific treatments; others resolve over time. Supportive treatment is needed for survivors of kernicterus. Rehabilitative treatment is recommended for the specific neurological deficits.
Use of this content is subject to our disclaimer